SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-268364
Filing Date
2023-11-01
Accepted
2023-11-01 17:25:06
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d571960ds3.htm S-3 507077
2 EX-5.1 d571960dex51.htm EX-5.1 47552
3 EX-23.1 d571960dex231.htm EX-23.1 1680
4 EX-FILING FEES d571960dexfilingfees.htm EX-FILING FEES 53739
5 GRAPHIC g571960g76p34.jpg GRAPHIC 31996
6 GRAPHIC g571960page71.jpg GRAPHIC 2210
  Complete submission text file 0001193125-23-268364.txt   658489
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275256 | Film No.: 231369284
SIC: 2836 Biological Products, (No Diagnostic Substances)